Loading...
Rivaroxaban
India Pharmaceutical Trade Intelligence
Who Supplies Rivaroxaban to India from UNITED KINGDOM
India's rivaroxaban imports from UNITED KINGDOM total $91.8K across 36 shipments from 11 foreign suppliers. ESPEE PHARMA (UK) LTD leads with $37.5K in import value; the top 5 suppliers together control 93.3% of this origin. Leading Indian buyers include INDOCO REMEDIES LIMITED. This corridor reflects India's pharmaceutical import demand for rivaroxaban — a diversified sourcing base with multiple active suppliers from UNITED KINGDOM.
Top foreign suppliers (UNITED KINGDOM) — Ranked by import value
ESPEE PHARMA (UK) LTD is the leading Rivaroxaban supplier from UNITED KINGDOM to India, with import value of $37.5K across 5 shipments. The top 5 suppliers — ESPEE PHARMA (UK) LTD, M/S. NEW LIFE MEDICALS LLC, NEW LIFE MEDICALS LLC, LM MANUFACTURING LIMITED, NEWLIFE BIOPHARMA LIMITED — collectively account for 93.3% of total import value from this origin.
Top foreign suppliers (UNITED KINGDOM)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ESPEE PHARMA (UK) LTD | $37.5K | 5 | 40.8% |
| 2 | M/S. NEW LIFE MEDICALS LLC | $18.0K | 4 | 19.6% |
| 3 | NEW LIFE MEDICALS LLC | $15.3K | 12 | 16.7% |
| 4 | LM MANUFACTURING LIMITED | $7.8K | 5 | 8.5% |
| 5 | NEWLIFE BIOPHARMA LIMITED | $7.0K | 2 | 7.6% |
| 6 | ERAMOL (UK) LTD | $3.0K | 1 | 3.3% |
| 7 | PHARMAQUELLE LLC. | $1.5K | 1 | 1.6% |
| 8 | SIGMA PHARMACEUTICALS PLC | $1.4K | 2 | 1.5% |
| 9 | ROSEMONT PHARMACEUTICALS LTD | $230 | 1 | 0.3% |
| 10 | SYRI LIMITED T/A THAME LABS. (B&S GROUP) | $45 | 2 | 0.0% |
| 11 | SYRI LIMITED T/A THAME LABS B&S GROUP | $14 | 1 | 0.0% |
Showing top 11 of 11 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from UNITED KINGDOM)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | INDOCO REMEDIES LIMITED | $34.8K | 17 | 37.9% |
| 2 | TORRENT PHARMACEUTICALS LTD | $25.9K | 1 | 28.2% |
| 3 | AKUMS DRUGS AND PHARMACEUTICALS LIMITED | $11.6K | 4 | 12.6% |
| 4 | VERGO PHARMA RESEARCH PRIVATE LIMITED | $7.6K | 4 | 8.3% |
| 5 | IPCA LABORATORIES LIMITED | $7.0K | 2 | 7.6% |
| 6 | Persons /Institutions /Hospitals importing or expo | $3.0K | 1 | 3.3% |
| 7 | KOPRAN LIMITED | $1.4K | 2 | 1.5% |
| 8 | RAPTIM RESEARCH PRIVATE LIMITED | $230 | 1 | 0.3% |
| 9 | AUXILLA PHARMACEUTICALS AND RESEARCH LLP | $148 | 1 | 0.2% |
| 10 | FUSION SCIENTIFIC LABORATORIES PRIVATE LIMITED | $45 | 2 | 0.0% |
| 11 | GOWRIE RESEARCH PRIVATE LIMITED | $14 | 1 | 0.0% |
Import Statistics
- Import Value
- $91.8K
- Shipments
- 36
- Foreign Suppliers
- 11
- Indian Buyers
- 11
- Avg. Shipment
- $2.5K
Other Rivaroxaban Import Origins
Related Analysis
Frequently Asked Questions — Rivaroxaban Imports from UNITED KINGDOM
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Rivaroxaban suppliers from UNITED KINGDOM to India?
The top Rivaroxaban suppliers from UNITED KINGDOM to India include ESPEE PHARMA (UK) LTD, M/S. NEW LIFE MEDICALS LLC, NEW LIFE MEDICALS LLC. The leading supplier is ESPEE PHARMA (UK) LTD with import value of $37.5K USD across 5 shipments. India imported Rivaroxaban worth $91.8K USD from UNITED KINGDOM in total across 36 shipments.
QHow much Rivaroxaban does India import from UNITED KINGDOM?
India imported Rivaroxaban worth $91.8K USD from UNITED KINGDOM across 36 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Rivaroxaban from UNITED KINGDOM?
The main Indian buyers of Rivaroxaban sourced from UNITED KINGDOM include INDOCO REMEDIES LIMITED, TORRENT PHARMACEUTICALS LTD, AKUMS DRUGS AND PHARMACEUTICALS LIMITED. The largest buyer is INDOCO REMEDIES LIMITED with $34.8K in imports across 17 shipments.
QWhat is the total value of Rivaroxaban imports from UNITED KINGDOM to India?
The total value of Rivaroxaban imports from UNITED KINGDOM to India is $91.8K USD, across 36 shipments and 11 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: UNITED KINGDOM to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Rivaroxaban.
- 2.Supplier/Buyer Matching: 11 foreign suppliers from UNITED KINGDOM and 11 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $91.8K aggregated from 36 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
36 Verified Shipments
11 suppliers, 11 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists